By Dr .Muhammad Mosleh Uddin
âĸ
02 Aug, 2026
Can we predict diabetic CKD progression before albuminuria or eGFR starts to deteriorate?
đ´ Can we predict DKD progression before albuminuria or eGFR starts to deteriorate?
āĻāĻŽāϰāĻž āĻāĻāύ⧠Diabetic Kidney Disease (DKD) āύāĻŋāϰā§āĻŖā§ā§āϰ āĻāύā§āϝ āĻŽā§āϞāϤ albuminuria āĻāĻŦāĻ eGFR-āĻāϰ āĻāĻĒāϰ āύāĻŋāϰā§āĻāϰ āĻāϰāĻŋāĨ¤
āĻāĻŋāύā§āϤ⧠āϏāĻŽāϏā§āϝāĻž āĻšāϞā§, āĻāĻ marker āĻā§āϞ⧠āĻ
āύā§āĻ āϏāĻŽā§ kidney damage āĻļā§āϰ⧠āĻšāĻā§āĻžāϰ āĻ
āύā§āĻ āĻĒāϰ⧠āĻĻā§āĻāĻž āϝāĻžā§āĨ¤
āϤāĻžāĻ āĻŦāϰā§āϤāĻŽāĻžāύ nephrology research-āĻāϰ āϏāĻŦāĻā§ā§ā§ concern āĻāϰ āĻŦāĻŋāώ⧠āĻšāϞā§,
đ´ Can we predict DKD progression before albuminuria or eGFR starts to deteriorate?
āĻāĻ āĻĒā§āϰāĻļā§āύā§āϰ āĻāϤā§āϤāϰ āĻā§āĻāĻāϤā§āĻ āĻŦāĻŋāĻļā§āĻŦāĻā§ā§ā§ āĻāϞāĻā§ intensive research on novel biomarkers.
āĻāĻŦāĻ āĻāϞāĻšāĻžāĻŽāĻĻā§āϞāĻŋāϞā§āϞāĻžāĻš āĻāĻŽāϰāĻž āĻĒā§ā§ā§āĻ āĻā§āϞāĻžāĻŽ āĻāĻŋāĻā§ promising early biomarkers of diabetic CKD.
āĻāĻāĻā§ briefly āĻŦāϞāĻŋ āĻāĻĒāύāĻžāĻĻā§āϰ āĻāύāĻļāĻž āĻāϞā§āϞāĻžāĻšāĨ¤
đ´ Urinary NGAL (Neutrophil Gelatinase-Associated Lipocalin)
đ Detects early tubular injury
đ May rise even before albuminuria
đ´ KIM-1 (Kidney Injury Molecule-1)
đMarker of proximal tubular damage
đPredicts faster kidney function decline
đ´ Cystatin C
đMore sensitive than serum creatinine
đBetter reflects early decline in GFR
đ´ Urinary L-FABP
đIndicates renal hypoxia and oxidative stress
đ Useful in detecting early DKD
đ´ TNFR-1 & TNFR-2
đAmong the strongest predictors of DKD progression
đAssociated with future end-stage kidney disease
đ´ Soluble Uromodulin
đReflects tubular health
đLower levels may indicate higher risk of progression
đ´ Urinary MCP-1
đMarker of renal inflammation
đEmerging predictor of DKD progression
Kidney Extracellular Vesicle Biomarkers
đA promising frontier in precision nephrology
đStill largely confined to research settings
āϝāĻĻāĻŋ āĻāĻŦāĻŋāώā§āϝāϤ⧠āĻāĻ biomarkers-āĻā§āϞ⧠routine clinical laboratory āϤ⧠āĻ
āĻāĻļ āĻšāϝāĻŧā§ āϝāĻžāϝāĻŧ, āϤāĻžāĻšāϞ⧠āĻāĻŽāϰāĻž high-risk patients āĻĻā§āϰ āĻ
āύā§āĻ āĻāĻā§āĻ āĻļāύāĻžāĻā§āϤ āĻāϰāϤ⧠āĻĒāĻžāϰāĻŦā§ āĻāύāĻļāĻž āĻāϞā§āϞāĻžāĻšāĨ¤ āĻāĻŦāĻ Chronic Kidney Disease (CKD) progression prevent āĻāϰāϤ⧠āĻĒāĻžāϰāĻŦā§ āĻā§āĻŦ initial stage āĻĨā§āĻā§āĻ āĻāύāĻļāĻž āĻāϞā§āϞāĻžāĻšāĨ¤
āĻāĻ info āĻā§āϞ⧠āϝā§āĻ research paper āĻāϰ āĻāĻĒāϰ based āĻāϰ⧠āϞāĻŋāĻāĻž āϏā§āĻā§āϞā§āϰ link āύāĻŋāĻā§ āĻĻāĻŋāϞāĻžāĻŽ āĻāϞāĻšāĻžāĻŽāĻĻā§āϞāĻŋāϞā§āϞāĻžāĻšāĨ¤
Dr. Muhammad Mosleh Uddin
MBBS (CMC). FCPS P1 (Cardiology)